Skip to main content
. 2018 Apr 26;8:93. doi: 10.1038/s41398-018-0138-2

Table 2.

The 25 variable CpGs identified in converters as clinically relevant epimutations

CpG p-value of F-test (FDR) Genes
cg18796523 8.46E−04 ALG11; ATP7B
cg04087237 4.41E−02 CACNB4
chr16:50203861 9.91E−03
cg13303475 1.10E−02 NT5DC3
cg01918706 4.37E−02 UBE2T
cg01657694 3.09E−02 KLHL22
cg13694867 2.54E−02 SIM2
cg05168033 1.24E−03 EFEMP1
cg26952925 1.16E−02 ADCY9
cg13562542 5.93E−03 GPR27; EIF4E3
cg17364044 3.10E−02 PELI1
cg26447413 2.02E−02 GAS1
cg11265160 1.48E−02 TMEM132C
cg21849932 1.87E−02 LIME1
cg04364540 4.27E−03 FAM160B1
cg14099514 1.02E−02 PLCXD3
cg19176559 3.46E−03
cg19041132 6.22E−07 SPHK1
cg12053442 2.85E−02
cg01558909 1.85E−05 HBM
cg14993491 4.54E−03 PCSK9
cg13408519 3.24E−06
cg12604181 1.04E−09 CTSH
cg18404925 1.50E−07 RAC1
cg13978347 1.08E−04 ASTN2

Significance in F-test are corrected by FDR